• Balchem secured Thailand FDA approval for OptiMSM, expanding regulatory clearance for its branded methylsulfonylmethane ingredient.
• Approval supports broader product development options in sports nutrition, with OptiMSM positioned for exercise recovery applications.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Balchem Corporation published the original content used to generate this news brief on April 16, 2026, and is solely responsible for the information contained therein.